C83.89 Other non-follicular lymphoma, extranodal and solid organ sites

Name of the Condition

• Other Non-Follicular Lymphoma, Extranodal and Solid Organ Sites (ICD-10: C83.89)

Summary

This condition is a subtype of non-Hodgkin lymphoma characterized by the abnormal growth of non-follicular lymphocytes, which are a type of white blood cell involved in the immune response. It falls within the broader category of non-follicular lymphomas and may involve B-cells or T-cells in lymph nodes or other lymphoid tissues. The term "extranodal and solid organ sites" specifies that the lymphoma occurs outside of lymph nodes, in organs or tissues such as the gastrointestinal tract, skin, or other solid organs.

Causes

The exact cause of other non-follicular lymphoma is not fully understood. It may involve genetic mutations or alterations in the immune system. Environmental factors and prior infections, such as with the Epstein-Barr virus, could also play a role.

Risk Factors

• Older age.
• A family history of lymphomas.
• Exposure to certain chemicals and radiation.
• Conditions that compromise the immune system.

Symptoms

• Swollen, painless lymph nodes (if nearby).
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.
• Organ-specific symptoms depending on the site (e.g., abdominal pain, skin lesions).

Diagnosis

Diagnosis typically involves a combination of imaging tests such as CT or MRI scans, blood tests, and a biopsy of the affected tissues to confirm the presence and type of lymphoma cells. Laboratory analysis may also include immunophenotyping or molecular testing to characterize the lymphoma subtype. The anatomical location of the lymphoma is documented to determine the specific code.

Treatment Options

• Chemotherapy: Systemic drugs to target and kill cancer cells.
• Immunotherapy: Drugs that help the immune system recognize and attack cancer cells.
• Radiation therapy: Targeted radiation to shrink tumors or relieve symptoms.
• Stem cell transplant: For advanced or relapsed cases.
• Targeted therapy: Drugs that target specific genetic changes in cancer cells.

Prognosis and Follow-Up

Prognosis depends on factors such as the lymphoma subtype, stage, and overall health. Regular follow-up with imaging, blood tests, and clinical evaluations is important to monitor for recurrence or progression. Treatment response and long-term outcomes vary by individual.

Complications

• Organ dysfunction due to tumor growth or treatment.
• Infection risk from weakened immune system.
• Treatment-related side effects (e.g., fatigue, nausea).
• Lymphoma recurrence.

Lifestyle & Prevention

• Maintain a healthy lifestyle to support immune function.
• Avoid known environmental risk factors (e.g., excessive radiation, certain chemicals).
• Stay up-to-date with vaccinations to reduce infection risk.
• Follow medical advice for managing underlying conditions that may compromise immunity.

When to Seek Professional Help

Seek medical attention if you experience persistent symptoms such as unexplained weight loss, fever, night sweats, or swollen lymph nodes. Prompt evaluation is important for early diagnosis and treatment.

Tips for Medical Coders

Document the specific extranodal or solid organ site of the lymphoma to assign the correct code. Ensure clinical documentation specifies the anatomical location (e.g., gastrointestinal tract, skin) to support accurate coding. Review pathology reports and imaging findings to confirm the site and subtype of lymphoma.